Form 4 for NEO NEOGENOMICS INC
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-06 · accession 0001077183-21-000256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | 2021-12-06 | NEO | Mallon Mark | CEO, Dir | P - Purchase | $30.63 | +17.0K | 72.7K | +31% | +$520.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-06 | P | A | 17,000 | $30.63 | 72,736 | D | — | — |